ICO
Closing Date:

Seeking Neuroprotective Agents for Retinal and Ocular Conditions

Seeking Neuroprotective Agents for Retinal and Ocular Conditions

Johnson & Johnson are a global pharmaceutical company with a strong track record of successful academic collaborations. They are interested in identifying research focused on novel treatments for retinal and ocular conditions.

Approaches of Interest

Johnson & Johnson are looking for any novel compounds or targets which could be used for retinal neuroprotection. This includes prevention of photoreceptor/retinal ganglion cell (RGC) apoptosis or degeneration.

The photoreceptor/RGC degeneration can be linked to any condition, but Johnson & Johnson are particularly...

To see the full details and submit your response please register now

Benefits of registration:

  • Receive updates on the latest industry calls
  • Quickly and easily respond to calls via your dashboard
  • Build your academic profile

Opportunity types being sought:

  • Technology
  • Academic Researcher
  • Centre of Excellence
  • Research Project
  • Spinout Company

Essential Information

Submission Form

Share this call with professional partners.